Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Washington Court Hotel

25 sep 2013 8:00 a.m. - 27 sep 2013 5:00 p.m.

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

Steven  Broadbent

Steven Broadbent

Vice President of Quality

NITTO DENKO Avecia Inc., United States

Speaker(s)

Hüseyin  Aygün, PHD

Application of Process Analytical Techniques (PAT) in Oligonucleotide Synthesis

Hüseyin Aygün, PHD

BioSpring GmbH, Germany

Chief Scientific Officer

David  Macdonald

Design Space Understanding Using LCMS Impurities Analysis

David Macdonald

Agilent Technologies, United States

Director of Commercial Launch

David  Macdonald

Panelist

David Macdonald

Agilent Technologies, United States

Director of Commercial Launch

Anthony  Scozzari

Panelist

Anthony Scozzari

Ionis Pharmaceuticals, Inc., United States

VP, Development Chemistry & Manufacturing

Hüseyin  Aygün, PHD

Panelist

Hüseyin Aygün, PHD

BioSpring GmbH, Germany

Chief Scientific Officer

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.